Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

258 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pre-Diagnosis Dietary Patterns and Risk of Multiple Myeloma in the NIH-AARP Diet and Health Study.
Castro F, Parikh R, Eustaquio JC, Derkach A, Joseph JM, Lesokhin AM, Usmani SZ, Shah UA. Castro F, et al. Among authors: usmani sz. medRxiv [Preprint]. 2023 Sep 23:2023.09.20.23295639. doi: 10.1101/2023.09.20.23295639. medRxiv. 2023. Update in: Leukemia. 2024 Feb;38(2):438-441. doi: 10.1038/s41375-023-02132-3 PMID: 37790335 Free PMC article. Updated. Preprint.
Bortezomib, Lenalidomide and Dexamethasone (VRd) vs Carfilzomib, Lenalidomide and Dexamethasone (KRd) as Induction Therapy in Newly Diagnosed Multiple Myeloma.
Tan CR, Derkach A, Nemirovsky D, Ciardiello A, Diamond B, Hultcrantz M, Hassoun H, Mailankody S, Shah U, Maclachlan K, Patel D, Lahoud O, Landau H, Chung D, Shah G, Scordo M, Giralt S, Lesokhin A, Usmani S, Landgren O, Korde N. Tan CR, et al. Res Sq [Preprint]. 2023 Feb 24:rs.3.rs-2583053. doi: 10.21203/rs.3.rs-2583053/v1. Res Sq. 2023. Update in: Blood Cancer J. 2023 Jul 25;13(1):112. doi: 10.1038/s41408-023-00882-y PMID: 36865246 Free PMC article. Updated. Preprint.
Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies.
Howard AJ, Concepcion I, Wang AX, Hamadeh IS, Hultcrantz M, Mailankody S, Tan C, Korde N, Lesokhin AM, Hassoun H, Shah UA, Maclachlan KH, Rajeeve S, Landau HJ, Scordo M, Shah GL, Lahoud OB, Chung DJ, Giralt S, Usmani SZ, Firestone RS. Howard AJ, et al. Among authors: usmani sz. Blood Adv. 2024 Jun 25;8(12):3246-3253. doi: 10.1182/bloodadvances.2024012871. Blood Adv. 2024. PMID: 38621239 Free PMC article.
Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma.
Firestone RS, Socci ND, Shekarkhand T, Zhu M, Qin WG, Hultcrantz M, Mailankody S, Tan CR, Korde N, Lesokhin AM, Hassoun H, Shah U, Maclachlan KH, Rajeeve S, Landau HJ, Scordo M, Shah GL, Lahoud OB, Giralt S, Murata K, Usmani SZ, Chung DJ. Firestone RS, et al. Among authors: usmani sz. Blood. 2024 Jul 25;144(4):402-407. doi: 10.1182/blood.2023023557. Blood. 2024. PMID: 38728378
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma.
Cirrincione AM, Poos AM, Ziccheddu B, Kaddoura M, Bärtsch MA, Maclachlan K, Chojnacka M, Diamond B, John L, Reichert P, Huhn S, Blaney P, Gagler D, Rippe K, Zhang Y, Dogan A, Lesokhin AM, Davies F, Goldschmidt H, Fenk R, Weisel KC, Mai EK, Korde N, Morgan GJ, Usmani S, Landgren O, Raab MS, Weinhold N, Maura F. Cirrincione AM, et al. Blood. 2024 Aug 15;144(7):771-783. doi: 10.1182/blood.2024024299. Blood. 2024. PMID: 38728430
Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple Myeloma.
Maura F, Kaddoura M, Poos AM, Baughn LB, Ziccheddu B, Bärtsch MA, Cirrincione A, Maclachlan K, Chojnacka M, Diamond B, Papadimitriou M, Blaney P, John L, Reichert P, Huhn S, Gagler D, Zhang Y, Dogan A, Lesokhin AM, Davies F, Goldschmidt H, Fenk R, Weisel KC, Mai EK, Korde N, Morgan GJ, Rajkumar SV, Kumar S, Usmani S, Landgren O, Raab MS, Weinhold N. Maura F, et al. bioRxiv [Preprint]. 2024 Sep 4:2024.08.30.610457. doi: 10.1101/2024.08.30.610457. bioRxiv. 2024. PMID: 39282268 Free PMC article. Preprint.
Evaluating serum free light chain ratio as a biomarker in multiple myeloma.
Akhlaghi T, Maclachlan K, Korde N, Mailankody S, Lesokhin A, Hassoun H, Lu SX, Patel D, Shah U, Tan C, Derkach A, Lahoud O, Landau HJ, Shah GL, Scordo M, Chung DJ, Giralt SA, Usmani SZ, Landgren O, Hultcrantz M. Akhlaghi T, et al. Among authors: usmani sz. Haematologica. 2024 Oct 3. doi: 10.3324/haematol.2024.285531. Online ahead of print. Haematologica. 2024. PMID: 39363855 Free article.
Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies.
Diamond B, Chahar D, Jain MD, Poos AM, Durante M, Ziccheddu B, Kaddoura M, Papadimitriou M, Maclachlan K, Jelinek T, Davies F, Figura NB, Morgan G, Mai E, Weisel KC, Fenk R, Raab MS, Usmani S, Landgren O, Locke FL, Goldschmidt H, Schatz JH, Weinhold N, Maura F. Diamond B, et al. bioRxiv [Preprint]. 2024 Nov 18:2024.11.15.623836. doi: 10.1101/2024.11.15.623836. bioRxiv. 2024. PMID: 39605649 Free PMC article. Preprint.
Artificial intelligence enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicity.
Shaffer BC, Brown S, Chinapen S, Mangold KE, Lahoud O, Lopez-Jimenez F, Schaffer W, Liu J, Giralt S, Devlin S, Shah G, Scordo M, Papadopoulos E, Landau H, Usmani S, Perales MA, Friedman PA, Gersh BJ, Attia IZ, Noseworthy PA, Kosmidou I. Shaffer BC, et al. Blood Adv. 2024 Nov 12;8(21):5603-5611. doi: 10.1182/bloodadvances.2024013636. Blood Adv. 2024. PMID: 39158065 Free PMC article.
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Dimopoulos MA, Oriol A, Nahi H, San-Miguel J, Bahlis NJ, Usmani SZ, Rabin N, Orlowski RZ, Komarnicki M, Suzuki K, Plesner T, Yoon SS, Ben Yehuda D, Richardson PG, Goldschmidt H, Reece D, Lisby S, Khokhar NZ, O'Rourke L, Chiu C, Qin X, Guckert M, Ahmadi T, Moreau P; POLLUX Investigators. Dimopoulos MA, et al. Among authors: usmani sz. N Engl J Med. 2016 Oct 6;375(14):1319-1331. doi: 10.1056/NEJMoa1607751. N Engl J Med. 2016. PMID: 27705267 Free article. Clinical Trial.
258 results